Cowen Encouraged by Pliant's (PLRX) Data, Models $2.03B Peak Sales, Reiterates "Outperform"
Tweet Send to a Friend
Cowen analyst Ritu Baral reiterated an Outperform rating on Pliant Therapeutics (NASDAQ: PLRX), following the company's report of positive PLN-74809 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
